Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
4.310
-1.060 (-19.74%)
At close: Apr 10, 2026, 4:00 PM EDT
4.389
+0.079 (1.83%)
After-hours: Apr 10, 2026, 7:04 PM EDT
Harvard Bioscience Employees
As of December 31, 2025, Harvard Bioscience had 339 total employees, including 316 full-time and 23 part-time employees. The number of employees decreased by 16 or -4.51% compared to the previous year.
Employees
339
Change (1Y)
-16
Growth (1Y)
-4.51%
Revenue / Employee
$255,310
Profits / Employee
-$167,257
Market Cap
19.04M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 339 | -16 | -4.51% | 316 | 23 |
| Dec 31, 2024 | 355 | -61 | -14.66% | 330 | 25 |
| Dec 31, 2023 | 416 | -39 | -8.57% | 391 | 25 |
| Dec 31, 2022 | 455 | -39 | -7.89% | 436 | 19 |
| Dec 31, 2021 | 494 | 35 | 7.63% | 475 | 19 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Jin Medical International | 273 |
| Retractable Technologies | 227 |
| Bionano Genomics | 97 |
| Precision Optics Corporation | 90 |
| Femasys | 71 |
| Ekso Bionics Holdings | 55 |
| Nephros | 36 |
| Milestone Scientific | 17 |
HBIO News
- 4 weeks ago - Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Harvard Bioscience Announces Reverse Stock Split - GlobeNewsWire
- 5 weeks ago - Harvard Bioscience to Participate in KeyBanc's Virtual Healthcare Forum - GlobeNewsWire
- 6 weeks ago - Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET - GlobeNewsWire
- 2 months ago - Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas - GlobeNewsWire
- 2 months ago - Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth - GlobeNewsWire
- 4 months ago - Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package - GlobeNewsWire
- 5 months ago - Harvard Bioscience Announces Third Quarter 2025 Financial Results - GlobeNewsWire